Sep 02, 2021 Dr. Hippocrates

A modern day Noah in the form of a family physician…

Some people might remember Vladimir Zelenko MD as the otherwise obscure family physician who is a bit of an icon in his New York community and who was called upon to treat President Trump when he was infected with SARS-CoV-2. Many, of course, wished him ill and derided Dr Zelenko both for his “unproven” methods and because he was helping this particular president. However, all of his skills and treatments have  turned out to be incredibly prescient. A couple of weeks ago he held an unbelievable discussion with the rabbinical leaders in his Jewish community. This is required viewing to help those who are skeptical, fearful, and confused about what is going on right now in the world.  I will let him speak for himself.  If this plays poorly or keeps interrupting, go directly to the site here.

Apr 08, 2017 Dr. Hippocrates

Disturbing documentary alert…


On April 12 a documentary will be televised likely to create some tremblors in the medical world. That is, those medical people that are interested or alert enough to watch it. As we all know, the Procrustean Bed of medical Groupthink tends to get in the way of innovative and independent dialogue. This is true about many things these days such as global warming, gender-neutral bathrooms, and… the safety and efficacy of vaccines. It’s not so much that these subjects tend to be completely one-sided, but rather that one side is simply unmentionable in polite company. Well, this year all that is about to come to an end. when it comes to vaccines…



Mar 15, 2017 Dr. Hippocrates

If we could only patent broccoli…

If we could only patent broccoli….                                   Mark Berger MD

Disregarding the fact that dozens of statin trials have shown minimal or no benefit in reducing cardiovascular disease or postponing death, the latest enlightenment for statin treatment comes from the Merck sponsored IMPROVE-IT trial (Cannon, NEJM, 2015) which showed that adding ezetimide (which blocks intestinal absorption of cholesteroll) to simvastatin lowers LDL better than simvastatin alone, with the 2% absolute reduction in combined endpoints hailed as a significant breakthrough in the treatment of cardiovascular disease.  Two percent.  But relative risk falls 40% or more, and this is what the physician and patient public hears.  So an ABSOLUTE risk reduction of 3.6% to 2% is translated into a RELATIVE risk reduction of >40%.  That is deception by any other name. Yet another deceptive statin trial targeting elevated cholesterol as the primary cause of heart disease, when other underlying metabolic — or even infectious — mechanisms are at work and disregarded…


Feb 17, 2017 Dr. Hippocrates

The Demon in the Freezer…

…is the name of a 2003 book by best selling author, Richard Preston. I was very taken by The Hot Zone which he wrote almost 20 years ago about the emerging nasty viruses that came from central Africa, one of which was Ebola. But this next book, written in the shadow of 9/11, caught passing interest as it chronicled the famous anthrax letter that went to the Hart Congressional building addressed to then Senator Tom Daschle. Lost in the conversation was the reemergence of the potential apocalyptic consequences of weaponized smallpox…


Feb 12, 2017 Dr. Hippocrates

It’s Easter time, the Resurrection of Dietary Supplements…

Every once in a while something shows up in the medical “literature” that sort of stops you in your tracks. As many of you know, dietary supplements or “vitamins” have been one of the more maligned choices made by consumers as seen through the lens of the institutional medical experts. But Big Pharma has seen the light!


Jan 29, 2017 Jonathan Otten

Who will be the last physician?

One of the primary inspirations for the development of is that there is a shrinking number of physicians who can share their honest medical opinion without risk of losing their job. Physicians are generally highly intelligent, caring, and opinionated people. However, in the new world of Big Box Medicine and a powerful pharmaceutical industry, physicians who would like to have a job are discouraged and even disciplined for sharing an opinion that is not well within the status quo of “science.”

Earlier this month, Dr. Daniel Neides, medical director of the esteemed Cleveland Clinic’s Wellness Center, wrote a thoughtful blog where he raises the issue of toxins in our environment, including those which we inject directly in to our bloodstream.  When he recently got his flu shot, he chose the “preservative-free” option, and to his surprise found that while it didn’t contain thimerosal (a preservative that contains mercury, a potent neurotoxin), it still contained formaldehyde.  Since when is formaldehyde not a preservative?  I digress…  Dr. Neides’s thoughtful article is about limiting our total body burden of toxins and raising attention to the numerous preservatives and adjuvants in vaccines.  These agents, including aluminum, are burdening the underdeveloped immune systems and detoxification systems in infants at the very point in their development when their nervous system is rapidly developing.

His blog sparked a fierce backlash from all over…with other medical authorities denouncing him as “reckless,” “anti-science,” and even “dangerous.”  The prestigious Cleveland Clinic quickly responded with what I imagine was a coerced apology by Dr. Neides with the promise that he would be disciplined.  Dr. Neides’s statement read:

“I apologize and regret publishing a blog that has caused so much concern and confusion for the public and medical community. I fully support vaccinations and my concern was meant to be positive around the safety of them.”

The website published a great overview of this whole story on their website, and I would like to share one excerpt:

“If Neides does, in fact, receive the “disciplining” promised in the Clinic’s public statements, it will likely discourage other integrative physicians from voicing opinions that run counter to or are critical of mainstream medicine. That, in the long run, could be detrimental to the entire field of holistic and functional medicine and to healthcare in general. An atmosphere in which clinicians do not feel free to raise questions, publish observations and opinions, or explore alternative viewpoints, is one that will kill innovation.

And THAT, my friends, is my largest fear for the direction of medicine and the sole reason for the development of HippocratesWired. For when physicians no longer have a platform by which to raise questions, and when the science is declared to be settled; that is when real science is dead.

Who, I ask, will be the last physician?

Jan 12, 2017 Dr. Hippocrates

The next generation of medications for your mood…


…will likely have something to do with a fellow I studied with a while ago.  His name is Joe Moskal, and he has been a neuroscientist ever since I knew him as an undergrad at Notre Dame. Among the many areas of study to which he has applied his considerable intellect is that of the “NMDA receptor (N methyl D aspartate)”, a particular protein in and on our nerve cells that plays an in depth role in how nerve cells talk to each other. It would not be helpful to try to explain the finer dimensions of this science (as I do not understand them all that well myself). But the impact that is just around the corner could be profound.  The molecule pictured above is glutamate, the major neuroexcitatory substance in our brains, and its target is the NMDA receptor.


Dec 16, 2016 Dr. Hippocrates

Those darn, useless supplements…



…that we recently highlighted here after the JAMA editorialized about the stupid American public’s ongoing use of them. The scholarly publication — with absolutely NO ties to the drug industry — again warned us about the dangers and waste in their use a few weeks ago very likely because the pharmaceutical folks would love to get their hands on the money from their sales. So let’s demonize them first, regulate them, then take them over when hundreds of small supplement companies cannot possibly afford to deal with the newly created regulatory environment.